Results 161 to 170 of about 25,644 (242)
Massive Splenic Infarction: A Rare Entity in a Female Teenager. [PDF]
Moreno Fernandes M +4 more
europepmc +1 more source
ABSTRACT Extracellular vesicles (EVs) released from tissues can be found in human biofluids. EVs reflect the phenotypic state of their cell of origin, carrying informative molecular biomarkers within and between tissues, and represent a promising target for liquid biopsy.
Biancamaria Pierri +5 more
wiley +1 more source
Splenic Infarction at the Crossroads of Hematologic and Cardioembolic Risk. [PDF]
Annan GK +4 more
europepmc +1 more source
Subacute infective endocarditis presenting with an isolated splenic infarction. [PDF]
Baroudi MM +5 more
europepmc +1 more source
Neurons, immune cells, and other cellular components within the disease microenvironment (such as stromal cells and tumor cells) constitute a dynamically evolving ecosystem. Neurons directly modulate immune cell activity and inflammatory responses through the release of neurotransmitters (e.g., norepinephrine and CGRP), while also promoting tumor ...
Xin Guo +11 more
wiley +1 more source
Asymptomatic Splenic Infarction Following Total Gastrectomy: A Case Report. [PDF]
Takagi A +6 more
europepmc +1 more source
Treadmill training protects against white matter injury and reduces cerebral infarction. Muscle‐derived mitochondrial transfer via platelets is promoted by treadmill training. Platelet transfusion emerges as a potential low‐risk therapeutic strategy for sequelae and vascular dementia.
Toshiki Inaba +8 more
wiley +1 more source
A Rare Case of Yersinia Pseudotuberculosis Infection with Septic Shock and Splenic Infarction. [PDF]
Tan Y +6 more
europepmc +1 more source
A Fatal Etiology of Splenic Infarction. [PDF]
Masterman D +4 more
europepmc +1 more source
Progress in RNA‐Targeted Therapeutics for Human Diseases
RNA‐targeted therapies are revolutionizing molecular medicine by transitioning from a “protein‐centric” focus to an “RNA‐regulatory network” approach. Leveraging RNA's diverse roles in gene regulation, signaling, and epigenetic modifications, advanced platforms such as ASOs, siRNA, miRNA, mRNA, aptamers, shRNA, and CRISPR/Cas systems are enabling ...
Wangzheqi Zhang +10 more
wiley +1 more source

